Tango Therapeutics, Inc. (TNGX) Operating margin 2020–2025
Tango Therapeutics, Inc. (TNGX) operating margin by fiscal year — reported operating income divided by reported revenue.
-178.4%FY2025 · since FY2020: -681.8% → -178.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -178.4% | +167.7 pp |
| FY2024 | -346.1% | -33.5 pp |
| FY2023 | -312.6% | +134.2 pp |
| FY2022 | -446.8% | -289.7 pp |
| FY2021 | -157.1% | +524.7 pp |
| FY2020 | -681.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice